Spectral AI, Inc. Q1 Overview. Research & Development Revenue of $6.7 Million. Improved Capital Structure Reflected in Cash of $14.1 Million. Continued work on planned De Novo submission to the ...

Spectral has continued its significant progress throughout the first quarter of 2024 both clinically and operationally and year-to-date enrolled 25 patients for a total of 106 patients out of the ...